matt24d... Agree. Was not knocking Pharmas ; just trying to indicate that : as patents end, here and there, that some Pharmas (especially those with deep pockets) may very well bid up bio to compensate for their lack of success with R&D. IMO, bodes well for bio stocks: like- sell the company or the product to someone else for big gains.
Market Data 
Markets 
AI
